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ABSTRACT
Human High Temperature requirement A2 (HtrA2) also known as Omi, is a serine
protease located in the mitochondria with an important function in both cell survival and death.
My results show the proteolytic activity of Omi/HtrA2 varies under different conditions. I
characterized the optimal condition for Omi/HtrA2 protease activity using an in vitro assay
system. Additionally, I identified a new allosteric regulation of Omi/HtrA2 through interaction
with a specific substrate, the MUL1 protein. MUL1 is a multifunctional E3 ubiquitin ligase
anchored in the outer mitochondrial membrane with domains both inside mitochondria and in the
cytoplasm. The data shown here strongly supports the hypothesis that Omi/HtrA2 activity is
modulated by a number of different mechanisms. Some of these conditions, such as pH or
substrate denaturation might reflect the state of mitochondria under stress. It has been known that
Omi/HtrA2 is a stress activated protease, but the mechanism of its regulation has not been fully
elucidated. Furthermore, the allosteric regulation of Omi/HtrA2 by specific substrates, can be
another mechanism that provides a feedback loop to increase the activity of the enzyme. The
findings from this project contribute new information on the mechanisms of activation of
Omi/HtrA2 protease. They support the hypothesis that mitochondrial stress might be involved in
the regulation of Omi/HtrA2 protease.
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INTRODUCTION AND LITTERATURE REVIEW

Omi/HtrA2 Isolation and Characterization:
DegP/HtrA was first isolated in E. coli, and was considered to be essential to the survival
of microbes at high temperatures [2]. Later, it was discovered to be a serine protease in the
periplasm of the microbes with a function in the degradation of misfolded proteins [3]. Homologs
of the enzyme in E. coli include DegS and DegQ [4]. HtrA homologs were then promptly found
in many other species and in eukaryotes. Omi was originally isolated in our lab and later by several
other groups that named it HtrA2 based on its homology to bacterial HtrA protease [5] [6, 7]. The
protease is now referred to as Omi/HtrA2. Humans possess three homologs: HtrA1, Omi/HtrA2,
and HtrA3 (Figure 1A). Omi/HtrA2 is normally contained within the mitochondria, HtrA1 and 3
harbor secretion signals that indicate their likely function in the secretory pathway [8].
Omi/HtrA2’s precursor form, described in Figure 1B, contains a mitochondrial targeting
signal (MTS), transmembrane region, IAP binding motif, serine protease domain, and a C-terminal
postsynaptic density of 95 kDa, disk large, and zonula occludens 1 (PZD) domain that functions
to regulate chaperone and protease activity [9]. In its precursor form, Omi/HtrA2 is embedded in
the inner mitochondrial membrane. Through a process of autocleavage it is released into the
mitochondrial intermembrane space (IMS). The serine protease domain of Omi/HtrA2 plays an
important role in the formation of a pyramid shaped homotrimer (Figure 1C). In the trimeric form,
the PDZ domains usher in denatured or damaged proteins into the catalytic domain [10]. In
addition, the Omi/HtrA2 trimer can more easily be regulated by activator peptides that change the
oligomer between a closed or an open confirmation. This allows for tight regulation of the cleavage
of proteins, preventing any potential uncontrolled degradation of essential proteins [11].
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Figure 1: Homology and Structure of HtrA family of proteins
HtrA was first isolated in E. coli as DegS. Humans contain 3 homologs of HtrA: HtrA 1, 2, and 3. HtraA1/3 contain
secretion domains indicating their involvement in the secretion pathway (Figure A). Omi/HtrA2 is 458 amino acid
serine protease, with its catalytic serines located at amino acids 276 and 306. Omi/HtrA2 has a mitochondrial
targeting sequence, a transmembrane domain (aa 105 – 125; not labeled), a PDZ domain, an and an IAP targeting
AVPS domain (Figure B). Mature Omi/HtrA2 forms a homotrimeric pyramid, which is regulated by the PDZ
domains, and can be activated through substrate binding (Figure C).
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The Function of Omi/HtrA2 protease
The main function of Omi /HtrA2 is to act as a chaperone, refolding or degrading denatured
proteins in the mitochondrial intermembrane space (IMS) [12]. Through this process, Omi/HtrA2
is able to maintain homeostasis within the mitochondria. In addition, Omi/HtrA2 upon induction
of cell death, is released from the mitochondria to the cytoplasm where it participates in apoptosis
through caspase-dependent and independent mechanisms (Figure 2) [13-15]. Previous studies
have suggested that the proteolytic activity of Omi/HtrA2 could be regulated by mitochondrial
stress such as ROS, but the mechanism of this regulation remains unclear [16]. In addition, other
studies indicate that specific protein-protein interactions could affect the enzymatic activity of
Omi/HtrA2 and target the enzyme to specific substrates [17-19].
My study aims to investigate how various conditions such as temperature, pH, or the
denaturation state of the substrate could potentially affect the protease activity of this enzyme in
vitro. Furthermore, I will test the hypothesis that MUL1, a recently discovered substrate of
Omi/HtrA2, can act as an allosteric activator of the enzyme’s protease activity.
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Figure 2: Role of Omi/HtrA2 in Apoptosis
Signaling by pro-apoptotic proteins causes a termination of HtrA2/Omi’s normal function of protein regulation
inside the mitochondria and releases it into the cytosol together with cytochrome c and Smac/Diablo. There it
participates in caspase independent pathway through its serine protease activity, and in caspase dependent
pathway through the degradation of the caspase inhibitor IAP proteins.
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Implications for Disease
Due to the proapoptotic activity of Omi/HtrA2, it was thought inactivation of the protease
in mice would lead to increased proliferation and possibly tumors. However, Omi/HtrA2 KO
animals develop normally up until 20 days and then show signs of neurodegeneration with a
parkinsonian phenotype, a disorder labeled as motor neuron degenerative 2 (mnd2) in mice [20].
The mnd2 mice have rapidly developed paralysis, muscle loss, shrinking of the body, very small
thymus and spleen, as well as the namesake neurodegeneration (Figure 3) [21]. This usually
progresses quite rapidly and severely, leading to premature death within 40 days.
In humans, Parkinson’s Disease (PD), is classified by loss of dopaminergic neurons in the
central nervous system leading to tremors, stiffness, and loss of balance [22]. This disease has been
linked to the absence of Omi/HtrA2, as misfolded ∝-synuclein, a normal neuron factor, aggregates
and presents strong neurotoxicity causative of the dopaminergic neuronal degradation [23]. Loss
of Omi/HtrA2 has been shown to cause oligomeric ∝-syn induced toxicity [24]. This shows the
importance functioning Omi/HtrA2, with ideal levels of activity required to keep the body
functioning.

Figure 3: Phenotype of mnd2 mice
that carry a mutated Omi/HtrA2.
Mnd2 mice exhibit neurodegeneration,
muscle loss, paralysis, involuntary
movement, and after a period of 40
days, a premature death. Pictured left
is a normal healthy functioning WT
mouse. On the right and bottom are
mice with the mnd2 phenotype
exhibiting shrunken, disheveled bodies
and decrease in normal movement.
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Known Substrates of Omi/HtrA2 and Mechanism of Action
The mechanism of Omi/HtrA2 degradation is tightly regulated and influenced by a number
of factors. The protease forms a trimer that is regulated by the PDZ domains that block access to
the catalytic site of the serine protease domain. When activated by stimuli, the trimer progresses
into an open conformation allowing substrate access (Figure 4). Numerous important factors have
been considered in supporting the activation state.
One such factor is the phosphorylation of the Omi/HtrA2 serine protease. CDK5 dependent
phosphorylation of Omi/HtrA2 at residue S400 has been shown to maintain membrane potential
in the mitochondria, maintaining function during cellular stress [25]. Additionally, PINKdependent phosphorylation of Omi/HtrA2 has a similar effect and PINK is often mutated in
Parkinson’s patients [26].
Another important factor looked at is the ideal pH at which Omi/HtrA2 works at. Proteases,
like most enzymes, have different activities based on the pH of the surrounding environment.
Defining the optimum pH and locating where and when that pH occurs can help define the location
and timing that a given enzyme may become more active. The mitochondria boast a wide range of
pHs, in part due to the gradient of protons gained through respiration in the IMS [27]. The IMS
has a resting pH around 7.4. However, this value has been proven to change based on the conditions
of the cell and the state of OXPHOS [28]. The mitochondrial matrix (MM) on the other hand holds
a much higher pH range, around 7.9 - 8.0. Changes of the pH of the intermembrane space or the
mitochondrial matrix could coincide with defects of the mitochondria or with other cellular process
and are thus an important factor to be considered. Omi/HtrA2 functioning at different pH levels
could be a method of regulation both within the mitochondria and in the cytoplasm. Unlocking the
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ideal preforming pH could play a large role in pinpointing the timing and method of Omi/HtrA2
activity in the cell.
Temperature plays another role in Omi/HtrA2 activity. HtrA, originally isolated as DegP
in bacteria, was shown to become more activate when raised from temperatures of 30°C to those
of 42°C or above [29]. Additionally, it has been shown that HtrA can alter its activity based on the
temperature. At lower temperatures, 37°C, DegP has general molecular chaperone activity and is
able to stimulate refolding of chemically denatured substrates. Its proteolytic activity is almost
exclusively present at elevated temperatures, 42°C [30]. Although my experiment deals with
mammalian Omi/HtrA, the homology between the proteins could mean a similar mechanism could
play a role in other members of the HtrA family. Either way, temperature is an important factor to
consider is enzyme activity.
Another relevant factor discussed is the denaturation state of substrate prior to interaction
with Omi/HtrA2. Although the most common method for denaturing proteins in a laboratory is
increased temperature, this is highly unlikely to occur in vivo, as the body temperature is
maintained. There are many other methods of denaturing of proteins in vivo, such as chaperones,
changes in pH, or posttranslational modification which can all act independently or in unison to
denature a protein. Seeing how this process effects Omi/HtrA2 could help link other proteins to its
processes.
Allosteric activation provides another possible regulating mechanism for Omi/HtrA2. As
a protease, the function of Omi/HtrA2 is defined by the specific substrates it regulates. There are
a number of such substrates present in both the mitochondria and in the cytoplasm that play a role
in Omi/HtrA2 activation. HAX-1 is a multifunctional protein that plays a large part as an anti-
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apoptotic protein and was shown to interact and be cleaved by Omi/HtrA2 [31]. In addition, HAX1 has been shown to be an allosteric inhibitor of Omi/HtrA2 [18].
Another closely related example, is the GRIM-19 protein (gene associated with retinoic
and interferon induced mortality 19). GRIM-19 is a 16 kDa protein and a known substrate of
Omi/HtrA2. GRIM-19 was also shown through enzyme kinetics to interact with Omi/HtrA2, and
acts as an allosteric activator [32]. Although this case presents a similar set of circumstances to
our own, there are still some major differences. The key difference being that the protein interacts
with Omi/HtrA2 outside the IMS when Omi/HtrA2 is in the cytoplasm during induction of cell
death. Finding an allosteric activator that works inside the IMS to regulate Omi/HtrA2’s normal
pro-survival role within the mitochondria would be novel and highly significant.
Of particular interest to our laboratory is the protein MUL1 also named MULAN
(mitochondrial ubiquitin ligase activator of NFKB 1), GIDE (growth inhibition and death E3
ligase,) MAPL (mitochondria-anchored protein ligase), and RNF218 (RING Finger Protein 218).
MUL1 is a E3 mitochondrial ubiquitin protein ligase found imbedded in the outer mitochondrial
membrane (OMM)[33]. MUl1 is one of three mitochondrial E3 ubiquitin ligases, with RNF185
and MARCH5 making up the other two [34, 35] (Figure 5). MUL1 has been identified as a specific
substrate of Omi/HtrA2. It has a domain located in the IMS that likely interacts with the protease
[36]. This newly discovered interaction serves as the basis of our study as the knowledge that
Omi/HtrA2 degrades MUL1 in the IMS provides a specific substrate and a possible allosteric
activator.
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Figure 4: Trimeric Activation of HtrA2/Omi
Omi/HtrA2 activation has been linked to many factors. Circumstances like heat change, pH, and activation by substrate
can move the protease from a less active basal state, to an increased activation state. This regulation is tightly managed
by the PZD domains that block substrate binding to the serine proteases in the active state. (Image adapted from works
of Dr. Ayon Chakraborty)[1]

MUL
1

Figure 5: MUL1 and Omi/HtrA2 in the Mitochondria
Omi/HtrA2 is located with the IMS of the mitochondria. MUL1 is one of three E3 Ubiquinone ligase located in the
OMM, MARCH5 and RNF185 are the others. All three proteins have a RING finger domain facing the cytoplasm.
MUL1, circled in blue, contains a domain located within the IMS that is the likely interactor of Omi/HtrA2
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MATERIALS AND METHODS

pGEX-Mul130-352 for Protein Expression Polymerase Chain Reaction
MUL1 (amino acids 30-352) was cloned into pGEX-6P-1 using polymerase chain reaction
(PCR). The 5’ forward primer, with restriction sites for the enzyme EcoRI: 5’- GCG GAA TTC
CGG CAG AAG GCC CGG GTC TC-3’ and the 3’ reverse primer, with restriction sites for the
enzyme SalI: 5’-CTCC GTC GAC TTA GCT GTT GTA CAG GGG TAT CA-3’, were used to
encode the MUL1 sequences from 30-352. PCR reaction used 20 ng template DNA, 10 ρM of
primer 1 and 2 [Eurofins], 5 µl of (10X) PCR buffer + Mg2+ [NEW ENGLAND BioLabs], 100
µM dNTPs [Clontech], and 1.5 units of Taq polymerase [ThermoScientific] in dH2O for a total 20
µl volume. PCR cycles: denatured at 98°C for 30 seconds, annealed at 58°C for 30 seconds, and
elongated 72°C for 90 seconds, for 25 total cycles.

Preparation for Loading Gel Electrophoresis
DNA samples were prepared by adding 5 µl DNA with 5 µl of 10X gel loading buffer (30%
glycerol and 2% Orange-G in TAE). Prepared DNA samples were loaded along with
GeneRuler1kb Plus DNA ladder [ThermoScientific] to estimate the size of the DNA. The gel was
visualized with BIO-RAD ChemiDoc MP Imaging System
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Precipitation of DNA
PCR-DNA was mixed with precipitation buffer (10% 3M sodium acetate pH 5.5, 2 sample
volumes 100% EtOH) Samples were then stored at -20°C for 20 minutes. Samples were
centrifuged at 13,000 rpm for 20 minutes at 4°C. Supernatant was removed and 150 µl 70% EtOH
was added to the pellet. Samples were again spun 13,000 rpm for 5 minutes this time at room
temperature. Supernatant was removed and spun in vacuum till dry. Sample DNA was then
resuspended TAE.

Restriction Enzyme Digestion
50 µl DNA of precipitated DNA was combined with 10 µl 10X Restriction Enzyme Buffer
[NEW ENGLAND BioLabs ], 1 µl BSA (bovine serum albumen) [NEW ENGLAND BioLabs],1.5
µl of given restriction enzyme, EcoRI or XhoI [NEW ENGLAND BioLabs], and 37 µl H2O.
Mixtures were the set to incubate for 1-2 hours when using EcoRI or 4 hours when using XhoI.
After one hour, an additional 0.5 µl restriction enzyme was added. DNA was precipitated from
solution. Next the process was repeated with a second restriction enzyme.

DNA Ligation
2 µl of DNA was analyzed using gel electrophoresis to determine DNA concentration in
1ul of vector and 1 ul of insert. Then the vector and insert (combined at a 1:2 ration) were combined
with water, ligation buffer, ATP, and ligase and incubated at 21°C for 20 minutes, followed by
inactivation by raising the temperature to 70°C for 10 minutes. The samples were then stored at
4°C.
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Bacterial Transformation
3-4 µl plasmid DNA were added to 50 µl of electro-competent E. coli cells. After gentle mixing,
samples sat on ice for 5 minutes. Bacteria/DNA mixture was added to 0.2 cm electroporation
cuvettes. A pipette was readied with 1 ml SOC. Cuvettes were placed into BIO-RAD Gene Pulser
with metal facing cathodes, electroporated with a pulse of 2.5 kV at 400 Ω, then immediately the
SOC was added. The mixture was transferred to a 2ml microtubes and placed in the incubator at
37°C on rotator at 200 rpm for 1 hour. Agar plates(+Amp) were dried and warmed in incubator
for 20 minutes. 50 𝜇l transformed DNA/Bacteria was plated using glass beads. Plates were labeled
and placed in a 37°C incubator overnight.

Isolation of Plasmid DNA from Bacteria
A disposable inoculation loops was used to pick a single colony of bacteria from plate and
inoculate a 1.5 ml microtube of LB +AMP at 37°C overnight. The bacteria were then centrifuged
at 13,000 rpm for 3 minutes. The supernatant was removed and 250 µl Buffer P1[QIAGEN] was
added. Next, 250 µl Buffer P2 [QIAGEN] was added and gently mixed. Then 350 µl Buffer
N3[QIAGEN] was added and again gently mixed. The samples were centrifuged at 13,000 rpm
for 15 minutes. The supernatant was transferred to a QIAprep spin column and centrifuged for 1
minutes. The flow-through was then removed. This process repeated again with 500 µl Buffer
PB[QIAGEN], 750 µl Buffer PE[QIAGEN], and again to dry the column before eluting with 50
µl Buffer EB[QIAGEN]. To confirm that pGEX-MUL1was cloned in frame, the plasmid DNA
was sent for DNA sequencing.
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Making LB and Ampicillin Plates
LB broth (40 minutes for 500 ml containers) (LB Broth: 2L H2O, 20g bactotryptone, 10g yeast
extract, 20g NaCl, adjust pH to 7.2 with sodium hydroxide pellets) (For plate preparation add agar
15g/L) was sterilized by liquid cycle on autoclave. LB was removed from autoclave and place on
low stir until warm to touch. Stirring continued while ampicillin was added at a concentration of
100 𝜇g/ml. Media was poured in plates until the bottom was just covered and sat until set. Plates
were stored at 4°C, for up to 1 month.

Isolation of Recombinant Protein
10 ng GST-MUL1 plasmid DNA were added to BL21(DE3) E. coli electro-competent cells
(bacterial expression strain) and transformation was performed using methods previously
described. Inoculation loops were used to pick a single colony of bacteria from plate and inoculate
5 ml tube which was then grown overnight. 500 𝜇L of bacteria was added to 500 ml flask of LB +
AMP. Covered flask was placed in shaking incubator at 37°C at 250 rpm for 3 hours until OD =
0.8. 1 mM IPTG was added to the bacteria, and which continued to shake at 25°C at 250 rpm for
an additional 3 hours, followed by immediate cooling on ice. Bacteria was then transferred from
flasks into 250 ml centrifuge bottle being sure to balance the weights. Then bottles were spun in
large centrifuge using JLA rotor at 4°C at 7,000 rpm for 10 minutes. Supernatant was removed
and pellet stored at -80°C.
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Cell Lysis, Purification, and Protein Elution
Pellet was defrosted in 37 C water bath with 10-15 ml recombinant lysis buffer (25 mM Tris-HCl
pH 8, 100 mM NaCl, 0.1% Triton-X, Protease Inhibitors Tablet [ThermoFisher]). An inoculation
loop was used to break up pellet and mix. 5 ml pipette was then used tp break up pellet further
until resuspended. The solution was then transfer to a 50 ml centrifuge tube, bringing the total
volume up to 20ml with lysis buffer as needed. 0.5 ml of lysozyme was added at 1 mg/ml and
placed in 30°C water bath for 30 minutes. Lysing bacteria was placed on shaker for 15 minutes
until color change and viscosity is clumped. Next solution was sonicated for 1 minutes with 5
second pauses every 20 sec. Process was repeated 3 times per sample followed by centrifugation
at 12,000 rpm for 20 minutes at 4°C with JA rotor. GST (Glutathione Sepharose)-resin beads were
prepared with wash buffer (at 1/10 volume of protein/lysate) (GST wash buffer: 25 mM Tris-HCl
pH 8 = 500 ml). GST charged resin beads were washed with wash buffer (centrifuged and
supernatant removed). Protein supernatant of sonicated bacteria was added to column through
filter. The column was placed on a rotator at 4°C overnight. The beads + protein mixture was spun
for 3 minutes at 2000 rpm, with the supernatant removed and save. GST-wash buffer was added
to beads, then beads were slowly added to column ensuring that they lay evenly. GST wash buffer
was poured through column (up to 10 times column volume). Protein was eluted with elution buffer
(50 mM Tris-HCl pH 8, 20 mM reduced glutathione). Fractions were collected in up to 8 elution
tubes, 1.5 ml in 2 ml microtube. 20𝜇L of each elution was loaded and run on SDS-PAGE followed
by Coomassie Blue staining to visualize the amount and purity of recombinant protein obtained in
each elution.
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Processing of Recombinant Protein
When necessary, combined protein elutions of similar purity were placed into dialysis membrane
(6000-8000 KDa) about 2-3 inches in length. Air bubbles were removed, and the membrane
clamped shut on both ends. The membrane and contents were then placed with PEG (polyethylene
glycol compound) to concentrate for 2-4 hours, flipping and moving intermittently. PEG was
washed and the membrane was opened to remove any air bubbles from membrane. The membrane
was then resealed, and dialysis was performed by submerging the membrane in 2 L wash buffer
(200 mM NaCl, 20 mM Na2HPO4) stirring at 200 rpm at 4°C.

pH Variation Experiments
Omi/HtrA2 activity was tested in vitro using bacterially expressed mature HIS-Omi,
varying pH of sodium phosphate buffer (20mM Na2PO4, 200 mM NaCl) between pH 7.5 or 8.0.
Activity was monitored first by the degradation of both a generic substrate, -casein, and then the
Omi/HtrA2 specific substrate, MUL1. Samples were incubated at 37 C for 25 minutes or 90
minutes, respectively. The reaction was halted by the addition of sample buffer (5% SDS, 20%
glycerol, 5% 2-mercaptoethanol, 0.004% bromophenol blue, 0.124M Tris HCl pH 6.8) followed
by boiling for 5 minutes. 20𝜇l of each sample was then loaded and run on SDS-PAGE (12%
acrylamide). Visualization was accomplished using Coomassie Blue staining followed by destaining with de-staining solution (5% acetic acid, 10% methanol v/v). Pictures were taken on
BIORAD ChemiDoc MP Imaging System.
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Substrate Denaturing Experiments
The effect of denaturing the substrate before was tested by pre boiling the specific substrate MUL1
prior to incubation with Omi/HtrA2. Sodium phosphate buffer (20 mM Na2PO4, 200 mM NaCl,
pH 8.0) was added to the enzyme. Samples were incubated at 37 C for 90 minutes, loaded and
run on SDS-PAGE, and visualized via Coomassie Blue staining procedure mentioned previously.
Additional visualization of protein degradation was accomplished through Western Blot and
analyzed with chemiluminescent and X-ray film.

Temperature Variation Experiments
Enzyme activity was tested at differing temperature by incubating Omi/HtrA2 with substrate, in
sodium phosphate buffer (20 mM Na2PO4, 200 mM NaCl, pH 8.0), at 37C or 42C for equal time
periods. The experiment was performed with either -casein or MUL1. Samples were then
incubated for 25 minutes, or 90 minutes respectively, followed by SDS-PAGE and visualization
via Coomassie Blue staining.

Allosteric Activation Experiments
The effect of MUL1, a specific substrate of Omi/HtrA2, as an allosteric activator was tested by
preboiling the substrate for 5 minutes. Then incubating Omi/HtrA2 in sodium phosphate buffer
(20mM Na2PO4, 200 mM NaCl, pH 8.0) and MUL1 at 37C or 90 minutes. The reactions are then
removed from incubation, and the generic substrate -casein is added, and the samples are returned
to incubate for an additional 25 minutes. Samples were then separated on SDS-PAGE and
visualized via Coomassie Blue staining.
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Western Blot Analysis
Samples were run on SDS-PAGE (12% acrylamide) and transferred to PVDF membrane using
transfer buffer (5x blot buffer, 20% v/v methanol) and a semi-dry apparat at 20V for 45 minutes.
Membrane was then placed in blocking solution of 5% milk in TBST (Tris Buffer Saline) (25 mM
Tris-HCl pH 8.0, 125 mM NaCl, 0.1% Tween 20) for one hour. The membrane was then incubated
with the primary antibody (rabbit anti-MUL1 1:3000) overnight with shaking at 4°C. The
membrane was then bought back to room temperature and washed 3 times for 15 minutes each
with TBST. The secondary antibody (anti-rabbit 1:10,000) was added to the membranes and
incubated at room temperature for 60 minutes. After this time the membrane was washed with
TBST for 3x15 minutes. The membrane was then soaked for 4 minutes with equal parts of Sol-1
and Sol-2 chemiluminescent solution prepared immediately before use, activated by H2O2 (Sol
1:10mM Tris-HCl pH8.5, 2.5 mM Luminol, 400 𝜇M 𝜌-coumaric acid; Sol 2:100 mM Tris-HCl
pH 8.5). The membrane was immediate visualized using X-ray films.

Image Analysis
All gel images were imported from the BIO-RAD ChemiDoc MP Imaging System and uploaded
via ImageJ. From here, images were analyzed and fitted. Then Photoshop was used to remove any
gel deformity (scratches, bubbles, nicks, blemishes, etc.) and to autotone the image for proper
paper presentation.
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Results
pH Experiments
Previous experiments have shown that Omi/HtrA2 has varying levels of activation under different
stress conditions. I have tested the effects of pH by altering the pH of the phosphate buffer used in
the reaction of Omi/HtrA2 with its substrate. Figure 6A shows the effect of increasing the pH on
the degradation of the generic substrate -casein. A general trend shows that as the pH increases,
the amount of cleavage, and hence the activation of Omi/HtrA2, also increases. There is a sharp
drop-off in activation at the last pH value, indicating a bell curve type of activation. Figure 6B
shows a more comparative example of the same experiment, choosing to focus on just the pH
found in the IMS and MM. There is clearly more degradation of the generic substrate -casein at
the higher pH value, indicating an increase in the activity of Omi/HtrA2. Lastly, in Figure 6C, the
comparison is repeated with the specific substrate MUL1. A similar conclusion to the generic casein substrate is found, with more degradation occurring at pH 8.0 than at pH 7.5, again showing
the increase of Omi/HtrA2 activation at this pH.
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Figure 6: Protease activity of Omi/HtrA2 at different pH
HIS-Omi protein presents at 37 kDa, usually displaying double bands caused by aggregation. -casein presents at
26 kDa, GST-MUL1 presents at 66 kDa, and free GST at 26 kDa. -casein, a generic substrate of the protease
Omi/HtrA2 undergoes degradation leading to bands of cleaved -casein at around 18 kDa. In figure 6A, lanes 1 and
9 are controls and show the substrate and enzyme, respectively. Lanes 2-8 show degradation of equal amounts of casein by Omi/HtrA2 at increasing. In figure 6B, lanes 1-3 with -casein are undergoing degradation by Omi/HtrA2
at pH 7.5, while lanes 4-6 show the same process at pH 8.0. In figure 6C, lanes 1-3 with the specific substrate
MUL1 undergoing degradation by Omi/HtrA2 at pH 7.5, while lanes 4-6 show the same process at pH 8.0. Proteins
were separated using SDS-PAGE and analyzed using Coomassie Blue staining.
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Pre-Denaturing Experiments
The effects of denaturing the substrates on Omi/HtrA2 activity was tested in a side-by-side
compassion of both versions of the specific substrates (Figure 7A). Only lane 4, containing the
denatured MUL1 with Omi/HtrA2 showed any significant change in MUL1 degradation. Because
of this, the samples were further analyzed using western blot analysis (Figure 7B). Here it is seen
that both the denatured and native MUL1 experience cleavage as a result of adding Omi/HtrA2.
Denaturing the MUL1 substrate by boiling has a significant effect, increasing the amount of the
degradation MUL1 seen by the smaller kDa protein bands as well as novel bands not found in the
non-boiled lane. In addition, there is a notable decrease in the MUL1 bands near the top of the
figure.
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Figure 7: MUL1 denatured vs MUL1 native
GST-MUL1 presents at 66 kDa, HIS-Omi/HtrA2 at 37 kDa, and free GST at 26 kDa. GST presents in
two bands due to aggregation, and endures some degradation due to Omi/HtrA2, the cleavage product
showing around 20 kDa. This experiment compares denatured MUL1 substrate with and without the
enzyme Omi/HtrA2, to its native counterpart. Figure A is separated on SDS-PAGE and analyzed by
Coomassie Blue staining, while figure B is analyzed by Western Blotting using mouse anti-MUL1
antibodies.
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Temperature Variation Experiments
The effects of temperature on Omi/HtrA2 activity were tested by comparing the degradation of
both the generic substrate, -casein, and the specific substrate, MUL1, at 37 ℃ and 42 ℃.
Although repeated numerous times, no indications of change in the activity of Omi/HtrA2
was seen between the two temperatures (Figure 8). Cleavage rates between the generic and
specific substrate showed insignificant changes.

Figure 8: Omi/HtrA2 activity at different temperatures
HIS-Omi protein is shown at 37 kDa, -casein presents at 26 kDa with cleaved -casein at around 18 kDa,
GST-MUL1 presents at 66 kDa , and free GST at 26 kDa. The experiment tests both the cleavage of the
generic substrate -casein and the specific substrate GST-MUL1 at 37℃ and 42℃. Lanes 7, 8, and 9 serve
as the control for -casein GST-MUL1 and HIS-Omi, respectively. Lanes 1-3 consider degradation of casein and MUL1 at 37℃. Lanes 4-6 consider degradation of -casein and MUL1 at 42℃. Proteins were
separated using SDS-PAGE and analyzed using Coomassie Blue staining.
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Allosteric Activation Experiments
The effects of MUL1 as an allosteric regulator of Omi/HtrA2 were tested by comparing the
cleavage of the generic substrate -casein, with and without pre-incubation with the specific
substrate MUL1. Figure 9 shows the lanes that had a pre-incubation with MUL1 and Omi/HtrA2
(Ln 4-5) had more overall degradation of the generic substrate -casein, in comparison to lanes
that had no MUL1 added before the addition of -casein to Omi/HtrA2 (Ln 5-6). The increase in
-casein degradation is indicative of increased Omi/HtrA2 activity.

Figure 9: Allosteric Activation of Omi/HtrA2 by MUL1
HIS-Omi protein is shown at 37 kDa, -casein presents at 26 kDa with cleaved -casein at around 18 kDa,
GST-MUL1 presents at 66 kDa, and free GST at 26 kDa. This experiment tests to see if GST-MUL1 acts as
in allosteric activator of Omi/HtrA2. Lanes 1, 8, and 9 serve as the control for GST-MUL1, HIS-Omi, and
-casein, respectively. Lanes 4 and 5 represent the experimental lanes showing the degradation casein after incubation with GST-MUL1. Lanes 2-3 and 4-5 represent comparison lanes showing
Omi/HtrA2 degradation on just GST-MUL1 and -casein alone. Indication of MUL1 presence can be
verified through the presence of the free GST only located in lanes containing GST-MUL1. Proteins were
separated using SDS-PAGE and analyzed using Coomassie Blue staining.
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Discussion
Omi/HtrA2 has many functions throughout the cell, including quality control of
mitochondrial proteins, autophagy, and apoptosis. Acting as a serine protease, it has many
substrates with numerous functions throughout the mitochondria and the rest of the cell. Although
much work has been done in investigating the substrates and the functions of Omi/HtrA2, there is
still much to be discovered. I looked to establish the environmental changes that affect activity of
Omi/HtrA2 to better understand its function, and possibly identify new functions based on the
information gathered. In addition, I aimed to identify a novel interaction of allosteric activation
between the substrate MUL1, hypothesizing that it would increase the activity of Omi/HtrA2 after
being degraded by the protease.
I performed many experiments testing different conditions, observing how the protease
activity of Omi/HtrA2 was affected. Figures 6A/B indicate that pH 8.0 is ideal for Omi/HtrA2
activity when presented with the generic substrate -casein. Figure C is less conclusive, as the
cleavage of MUL1 is difficult to ascertain using Coomassie Blue staining, but still showed
evidence of the same pattern seen with the generic substrate. Further experimentation using more
sensitive methods such as Western Blotting could confirm the ideas presented by the gel. If the
optimal pH is 8.0 as suggested in the gels, this is a key finding as the mitochondria is one of the
areas of the cell that can alter its pH due to the presence of proton pumps with the ETC. While
Omi/HtrA2 most commonly resides and works in the IMS where the pH in nearer 7.5, the matrix
is kept at high pH of 7.9-8.0. An increase in the pH in the IMS could be caused if OXPHOS is
inhibited and protons are not pumped to the IMS. In that case the activity of Omi/HtrA2 would
increase as a response to the mitochondrial condition. In addition, pH change can be an indicator
of cellular stress, causing many essential proteins to misfold. Omi/HtrA2’s increase in activity
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during these times of cellular stress would assist with the removal of misfolded or aggregated
proteins due to the change in pH.
The experiment testing the effect of pre-denaturing the substrate MUL1 before incubation
with Omi/HtrA2 showed very staggering results. Coomassie Blue staining indicated that
denaturing by boiling the substrate drastically effected the protease activity of Omi/HtrA2 during
the incubation period at 37 C. The results of the Western blot analysis (Figure 7B) acted further
to confirm this result. There was clear increase in the degradation of MUL1 after denaturing when
compared to regular native substrate. This is consistent with the role of Omi/HtrA2 as it is a quality
control enzyme for misfolded and denatured proteins, but additionally may indicate that its
interaction with MUL1 may be altered in vivo. Although our method of denaturation, bringing to
100 C, is not physiological, there are many other methods for protein denaturation, from pH
change as mentioned before, to ROS, to chaperones. Pursuing these ideas could lead to new
discoveries in the pathways already presented, or new pathways of regulation entirely. The drastic
amount of difference between the amount of protease activity itself warrants further investigation
into the relationship between Omi/HtrA2 and the MUL1 substrate.
The temperature variation experiment looked at the changes in protease activity in response
to different temperature during the incubation of Omi/HtrA2 with MUL1. Although, as previously
stated, the body temperature is highly regulated and unlikely to reach temperatures as high as 42
C, it is again a placeholder for other cellular mechanisms of increase and enzymes activity. For
example, a cellular catalyst could be involved in the process. In addition, increases in temperature
and heat shock damage experienced could lead to increased activation of Omi/HtrA2. Although
the data found was inconclusive (Figure 8), this pathway could be further ventured into to find a
more definite connection or lack thereof.
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The final experiment further explored the previously identified interaction between
Omi/HtrA2 and MUL1. According to Figure 9, there seems to be a clear increase in activity,
against the generic substrate -casein, when Omi/HtrA2 is pre-incubated with MUL1. This is an
important discovery. This suggests that a cleaved pieces of MUL1 bind to Omi/HtrA2 either
creating an open conformation or promoting the formation of the active hexamer complex [37].
The MUL1 ∝ sequence contains some promising segments that bare similar patterns to those seen
in peptides that promote activation in Omi/HtrA2 [17]. More experiments are necessary to confirm
these findings. Although the generic substrate -casein was used, applying the test to a specific
substrate of Omi/HtrA2 would further increase the legitimacy of the claims. In addition,
pinpointing the section of MUL1 that is responsible for the allosteric regulation of Omi/HtrA2
could be further explored and well as the cleavage sites in the MUL1 sequence.
In conclusion, the results from my experiments suggest that Omi/HtrA2 activity can be
regulated by multiple mechanisms that represent various states of mitochondrial dysfunction or
cellular stress. In addition, Omi/HtrA2 is involved in complex protein-protein interactions that
invariably affect its protease activity and target its degradation power against specific substrates.
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